Health Underperformance Now Seen as a Stepping Stone—Biotechs Make a Case for 2025. Determined biotech leaders foresee a transformative 2025, but what pivotal changes are on the horizon that could reshape the industry? Jordan LeeFebruary 2, 2025 View Post